Butylphthalide, a new medication that comes from celery seed, could improve outcomes after a clot-caused stroke when given in addition to prompt treatment for the clot, according to a new study.
Butylphthalide improved 90-day clinical outcomes in those with acute ischemic stroke who also received IV recombinant tissue plasminogen activator and/or endovascular treatment, per research presented at International Stroke Conference.“The medication was given to patients with acute ischemic stroke who were also receiving treatment to restore blood flow to the brain,” Baixue Jia, MD,